Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3152 results found

2024 ∙ Clari, M. Albanesi, B. Comoretto, R. I. Conti, A. Renzi, E. Luciani, M. Ausili, D. Massimi, A. Dimonte, V.

Effectiveness of interventions to increase healthcare workers' adherence to vaccination against vaccine-preventable diseases: a systematic review and meta-analysis, 1993 to 2022

  • Healthcare workers
  • Influenza
  • Tetanus
  • Diphtheria
  • Pertussis
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Abara, W. E. Kirkcaldy, R. D. Bernstein, K. T. Galloway, E. Learner, E. R.

Effectiveness of MenB-4C vaccine against gonorrhea: a systematic review and meta-analysis

  • Adolescents
  • Adults
  • Older adults
  • Meningococcal disease
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Wilburn, J. Sappe, B. Jorge, K. Hickey, L. Nandyala, D. Chadha, T.

Effectiveness of Pfizer Vaccine BNT162b2 Against SARS-CoV-2 in Americans 16 and Older: A Systematic Review

  • Americas
  • United States of America
  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Gong, J. Gu, D. Dong, S. Shen, W. Yan, H. Xie, J.

Effects of Message Framing on Human Papillomavirus Vaccination: Systematic Review

  • Parents/caregivers
  • All age groups
  • Human papillomavirus (HPV)
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Grant, L. R. Hanquet, G. Sepulveda-Pachon, I. T. Theilacker, C. Baay, M. Slack, M. P. E. Jodar, L. Gessner, B. D.

Effects of PCV10 and PCV13 on pneumococcal serotype 6C disease, carriage, and antimicrobial resistance

  • All age groups
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Sood, A. Raghavan, S. Mishra, D. Priya, H.

Effects of post-COVID-19 vaccination in oral cavity: a systematic review

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Santimano, A. J. Al-Zoubi, R. M. Al-Qudimat, A. R. Al Darwish, M. B. Ojha, L. K. Rejeb, M. A. Hamad, Y. Elrashid, M. A. Ruxshan, N. M. El Omri, A. Bawadi, H. Al-Asmakh, M. Yassin, A. Aboumarzouk, O. M. Zarour, A. Al-Ansari, A. A.

Efficacy and Clinical Outcomes of mRNA COVID-19 Vaccine in Pregnancy: A Systematic Review and Meta-analysis

  • Pregnant women
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2024 ∙ Raji, T. Fallah, M. P. Dereje, N. Kakooza, F. Ndembi, N. Abdulaziz, M. Aragaw, M. Kaseya, J. Ngongo, A. N.

Efficacy and effectiveness of COVID-19 vaccines in Africa: A systematic review

  • Africa
  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Whitworth, H. S. Mounier-Jack, S. Choi, E. M. Gallagher, K. E. Howard, N. Kelly, H. Mbwanji, G. Kreimer, A. R. Basu, P. Barnabas, R. Drolet, M. Brisson, M. Watson-Jones, D.

Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to multidose vaccination regimens or no vaccination: An updated systematic review of evidence from clinical trials

  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Jain, H. Odat, R. M. Hussein, A. M. Dey, D. Ahmed, M. Jain, J. Goyal, A. Ratnani, T. Idrees, M. Prajjwal, P. Passey, S. Yadav, R.

Efficacy and outcomes of BCG re-vaccination in COVID-19: a systematic review, meta-analysis, and meta-regression of randomized controlled trials

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Low
Loading...